- Home
- DEI vs CPRX Comparison
DEI vs CPRX Comparison
Compare DEI & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DEI
- CPRX
- Stock Information
- Founded
- DEI 1971
- CPRX 2002
- Country
- DEI United States
- CPRX United States
- Employees
- DEI N/A
- CPRX N/A
- Industry
- DEI Real Estate Investment Trusts
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- DEI Real Estate
- CPRX Health Care
- Exchange
- DEI Nasdaq
- CPRX Nasdaq
- Market Cap
- DEI 2.4B
- CPRX 2.9B
- IPO Year
- DEI 2006
- CPRX 2006
- Fundamental
- Price
- DEI $14.50
- CPRX $22.76
- Analyst Decision
- DEI Buy
- CPRX Strong Buy
- Analyst Count
- DEI 9
- CPRX 7
- Target Price
- DEI $18.50
- CPRX $32.29
- AVG Volume (30 Days)
- DEI 1.7M
- CPRX 1.0M
- Earning Date
- DEI 05-06-2025
- CPRX 05-07-2025
- Dividend Yield
- DEI 5.24%
- CPRX N/A
- EPS Growth
- DEI N/A
- CPRX 178.13
- EPS
- DEI 0.32
- CPRX 1.57
- Revenue
- DEI $995,663,000.00
- CPRX $534,645,999.00
- Revenue This Year
- DEI $0.56
- CPRX $15.59
- Revenue Next Year
- DEI N/A
- CPRX $8.90
- P/E Ratio
- DEI $45.78
- CPRX $14.51
- Revenue Growth
- DEI 1.93
- CPRX 29.97
- 52 Week Low
- DEI $12.39
- CPRX $14.47
- 52 Week High
- DEI $20.50
- CPRX $26.16
- Technical
- Relative Strength Index (RSI)
- DEI 50.81
- CPRX 46.01
- Support Level
- DEI $13.79
- CPRX $22.94
- Resistance Level
- DEI $14.63
- CPRX $25.01
- Average True Range (ATR)
- DEI 0.47
- CPRX 0.83
- MACD
- DEI 0.15
- CPRX -0.05
- Stochastic Oscillator
- DEI 85.36
- CPRX 46.56
About DEI Douglas Emmett Inc.
Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. It is an owner and operator of office and multifamily properties located in coastal submarkets in Los Angeles and Honolulu. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments, the office segment and the multifamily segment.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).